This Vanguard ETF Tops Schwab in Returns and Cost for Global Investors

Vanguard FTSE Developed Markets ETF (VEA) screens as the lower-cost option versus Schwab Emerging Markets Equity ETF (SCHE), with expense ratios of 0.03% vs 0.06% while both offer the same ~2.6% dividend yield. Over the trailing 12 months, VEA returned 28.6% vs SCHE’s 23.8%, and over 5 years it shows stronger growth-of-$1,000 outcomes ($1,611 vs ~$1,284) with a slightly smaller max drawdown (-29.7% vs -32.3%). The article highlights VEA’s more diversified developed-market exposure (largest holding ~2.99%) versus SCHE’s higher single-stock concentration risk in semiconductor exposure (e.g., Taiwan Semiconductor at ~17%).

Analysis

The main market implication is not “developed beats emerging” in a vacuum; it is that the cheaper, broader vehicle is the cleaner way to express non-U.S. exposure when the underlying EM basket is increasingly just a disguised Taiwan/China tech trade. That matters because allocator behavior tends to punish hidden single-name concentration once volatility rises in semis or China policy headlines turn noisy; SCHE is effectively carrying a much larger idiosyncratic beta load than its label suggests.

Second-order, the relative resilience of the developed-market basket should benefit European and Japan-heavy flows, especially financials and industrials that can outperform when global PMIs stabilize and rate cuts steepen yield curves. The underappreciated loser is the “EM growth premium” narrative: if TSM becomes the dominant driver of EM ETF returns, any pullback in the AI/semi cycle can mechanically drag SCHE even if broader EM fundamentals are fine. That makes the fund more vulnerable to factor crowding than to macro growth itself.

Time horizon matters: over days, this is mostly a flow/positioning story and likely too small to move either ETF materially. Over 1-3 months, a rotation out of crowded semiconductor exposures or fresh China risk premium could widen the performance gap; over 6-18 months, VEA’s broader country diversification and lower hidden concentration should keep compounding steadier unless emerging markets enter a synchronized growth upcycle. The contrarian view is that the fee differential is trivial and EM can outperform sharply in policy-driven rallies, so this is not a high-conviction structural short unless one has a bearish view on TSM and China liquidity simultaneously.

Key Decisions for Investors

• Prefer VEA over SCHE for core international exposure; if adding now, rotate incremental capital into VEA over 1-2 weeks rather than chasing the recent relative strength in EM tech proxies. Risk/reward: modest upside from continued allocator preference, with lower concentration risk than SCHE.
• Pair trade: long VEA / short SCHE on a 3-6 month horizon to express the view that broader developed-market diversification will outperform a semi-concentrated EM basket. Use equal dollar exposure; thesis breaks if TSM-led risk appetite accelerates or China stimulus turns into a broad EM re-rating.
• Treat TSM as the key read-through for SCHE rather than a “whole EM” proxy; if TSM loses momentum or gaps on guidance, expect SCHE to underperform broader global equities by more than its beta would imply. Alert level: a sustained break in TSM relative strength should be a de-risk signal for any SCHE exposure.
• If seeking international beta with less hidden single-name risk, consider VEA as the cleaner passive holding and avoid using SCHE as a stand-in for diversified emerging markets. The edge is small, but the drawdown profile should be better if semis or China headlines turn adverse.